1. 2020
  2. DisProt: intrinsic protein disorder annotation in 2020

    Hatos, A., Hajdu-Soltesz, B., Monzon, A. M., Palopoli, N., Alvarez, L., Aykac-Fas, B., Bassot, C., Benitez, G. I., Bevilacqua, M., Chasapi, A., Chemes, L., Davey, N., Davidovic, R., Dunker, A. K., Elofsson, A., Gobeill, J., Sudha, G., Guharoy, M., Horvath, T., Iglesias, V. & 43 othersKajava, A. V., Kovacs, O. P., Lamb, J., Lambrughi, M., Lazar, T., Leclercq, J., Leonardi, E., Macedo-Ribeiro, S., Macossay Castillo, M., Maiani, E., Manso, J. A., Marino-Buslje, C., Martinez-Perez, E., Mészáros, B., Micetic, I., Minervini, G., Murvai, N., Necci, M., Ouzounis, C., Pajkos, M., Paladin, L., Pancsa, R. A., Papaleo, E., Parisi, G. D., Pasche, E., Pereira, P. J. B., Promponas, V. J., Pujols, J., Quaglia, F., Ruch, P., Salvatore, M., Schad, E., Szabo, B., Szaniszlo, T., Tamana, S., Tantos, A., Veljković, N., Ventura, S., Vranken, W., Dosztányi, Z., Tompa, P., Tosatto, S. C. E. & Piovesan, D., 2020, In : Nucleic Acids Research. 47, D1, gkz975.

    Research output: Contribution to journalArticleResearchpeer-review

  3. 2019
  4. AXL Receptor Tyrosine Kinase as a Therapeutic Target in Hematological Malignancies: Focus on Multiple Myeloma

    Yan, S., Vandewalle, N., De Beule, N., Faict, S., Maes, K., De Bruyne, E., Menu, E., Vanderkerken, K. & De Veirman, K., 5 Nov 2019, In : Cancers. 11, 11, p. 1-17 17 p.

    Research output: Contribution to journalScientific reviewResearchpeer-review

  5. Detection of vertebral fractures in CT using 3D Convolutional Neural Networks

    Nicolaes, J., Raeymaeckers, S., Robben, D., Wilms, G., Vandermeulen, D., Libanati, C. & Debois, M., 5 Nov 2019, In : Lecture Notes in Computer Science. 11963

    Research output: Contribution to journalArticleResearchpeer-review

  6. Theranostics in immuno-oncology using nanobody derivatives

    Lecocq, Q., De Vlaeminck, Y., Hanssens, H., D'Huyvetter, M., Raes, G., Goyvaerts, C., Keyaerts, M., Devoogdt, N. & Breckpot, K., 25 Oct 2019, In : Theranostics. 9, 25, p. 7772-7791 20 p., 10.7150/thno.34941.

    Research output: Contribution to journalScientific reviewResearchpeer-review

  7. Theranostics in immuno-oncology using nanobody derivatives

    Lecocq, Q., De Vlaeminck, Y., Hanssens, H., D'Huyvetter, M., Raes, G., Goyvaerts, C., Keyaerts, M., Devoogdt, N. & Breckpot, K., 14 Oct 2019, In : Theranostics. p. 7772-7791 thno.34941.

    Research output: Contribution to journalSpecial issueResearch

  8. DNA methylation and mRNA expression of imprinted genes in blastocysts derived from an improved in vitro maturation method for oocytes from small antral follicles in polycystic ovary syndrome patients

    Saenz-de-Juano, M. D., Ivanova, E., Romero, S., Lolicato, F., Sánchez, F., Van Ranst, H., Krueger, F., Segonds-Pichon, A., De Vos, M., Andrews, S., Smitz, J., Kelsey, G. & Anckaert, E., 29 Sep 2019, In : Human Reproduction. 34, 9, p. 1640-1649 10 p.

    Research output: Contribution to journalArticleResearchpeer-review

  9. Noninvasive Imaging of the Immune Checkpoint LAG-3 Using Nanobodies, from Development to Pre-Clinical Use

    Lecocq, Q., Zeven, K., De Vlaeminck, Y., Martens, S., Massa, S., Goyvaerts, C., Raes, G., Keyaerts, M., Breckpot, K. & Devoogdt, N., 29 Sep 2019, In : Biomolecules. 9, 10, 20 p., 548.

    Research output: Contribution to journalArticleResearchpeer-review

  10. Antibodies targeting chemokine receptors CXCR4 and ACKR3

    Bobkov, V., Arimont, M., Zarca, A., De Groof, T., van der Woning, B., de Haard, H. & Smit, M. J., 3 Sep 2019, In : Molecular Pharmacology.

    Research output: Contribution to journalArticleResearchpeer-review

  11. Measuring the Pancreatic β Cell Mass in Vivo with Exendin SPECT during Hyperglycemia and Severe Insulitis

    Joosten, L., Brom, M., Peeters, H., Bos, D., Himpe, E., Bouwens, L., Boerman, O. & Gotthardt, M., 3 Sep 2019, In : Molecular Pharmaceutics. 16, 9, p. 4024-4030 7 p.

    Research output: Contribution to journalArticleResearchpeer-review

  12. Providing both autologous and allogeneic hematopoietic stem cell transplants (HSCT) may have a stronger impact on the outcome of autologous HSCT in adult patients than activity levels or implementation of JACIE at Belgian transplant centres.

    Poirel, HA., Vanspauwen, M., Macq, G., De Geyndt, A., Maertens, J., Willems, E., Selleslag, D., Poiré, X., Theunissen, K., Graux, C., Kerre, T., Zachée, P., Meuleman, N., De Becker, A., Verlinden, A., Van Obbergh, F., Schuermans, C., De Wilde, V., Jaspers, A., Pranger, D. & 4 othersDeeren, D., Van Riet, I., Vaes, E. & Beguin, Y., 1 Sep 2019, In : Bone Marrow Transplantation. 54, 9, p. 1434-1442 9 p.

    Research output: Contribution to journalArticleResearchpeer-review

Previous 1 2 3 4 5 6 7 8 ...126 Next

ID: 18917